Why Is Pfizer Teaming Up With Acuitas Therapeutics?

·3 min read

Pfizer (NYSE: PFE) is putting some of its growing cash stockpile to use. The big drugmaker recently announced a collaboration with Acuitas Therapeutics. In this Motley Fool Live video, recorded on Jan. 12, Fool contributors Keith Speights and Brian Orelli discuss why Pfizer is teaming up with Acuitas.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting